Hypolipidaemic drugs and industrial plasticizers such as di-(2-ethylhexyl) phthalate, which cause proliferation of hepatic peroxisomes, also cause an increase in an 80 000-mol.wt. polypeptide in the liver of rats and mice. This polypeptide has been designated as PPA-80 (PPA, for peroxisome-proliferation-associated; 80 for 80000mol.wt.). The polypeptide PPA-80 was purified to over 90% purity from livers of rats treated with the peroxisome proliferators Wy-14,643, nafenopin, tibric acid and clofibrate by a single-step preparative sodium dodecyl sulphate/polyacrylamidegel-electrophoretic procedure. The antibodies raised against the PPA-80 polypeptide isolated from livers of rats treated with Wy-14,643 cross-reacted with polypeptide PPA-80 purified from the livers of rats treated with Wy-14,643, as well as from the livers of rats treated with nafenopin, tibric acid and clofibrate. The anti-(polypeptide PPA-80) antibodies did not cross-react with catalase, a marker enzyme for peroxisomes, or with NADPH-cytochrome P-450 reductase, which has the same approximate mol.wt., 80000. The intensity of immunoprecipitin bands formed with microsomal, large-particle and postnuclear fractions from livers of animals pretreated with peroxisome proliferators was significantly greater compared with equal amounts of protein from corresponding fractions obtained from control animals, suggesting that these agents all enhance the synthesis of the same 80000-mol.wt. polypeptide. Although the polypeptide PPA-80 was increased in the postnuclear, large-particle and microsomal fractions of livers of rats pretreated with peroxisome proliferators, the relative abundance of this peptide in the peroxisome-rich light-mitochondrial fraction and its lack in highly purified mitochondrial fractions suggest the localization of this polypeptide in peroxisomes and/or microsomal fraction. Additional studies are needed to establish unequivocally the subcellular localization of the polypeptide PPA-80 and to ascertain if this polypeptide is identical with the multi-functional protein displaying enoyl-CoA hydratase and fJ-hydroxyacyl-CoA dehydrogenase activities that was purified by Osumi & Hashimoto [(1979) Biochem. Biophys. Res. Commun. 89, 580-584].
& Lazarow, 1977; Moody & Reddy, 1978a,b; Svoboda, 1978) . In addition, these drugs exert a variety of effects on other subcellular organelles; of particular interest are an increase in mitochondrial protein content (Krishnakantha & Kurup, 1972) and the proliferation of smooth endoplasmic reticulum Kolde et al., 1976; Anthony et al., 1978) .
Since phenobarbital and other xenobiotics that induce microsomal mono-oxygenases (Conney, 1967) are known to increase the amounts of the microsomal-membrane polypeptides in liver (Alvares & Siekevitz, 1973; Sharma et al., 1979) , we used SDS/polyacrylamide-gel electrophoresis to examine the polypeptide composition of postnuclear, large-particle and microsomal membranes obtained from livers of rats treated with the hypolipidaemic drugs clofibrate, nafenopin { 2-methyl -2-[p-(1,2,3,4-tetrahydro-1 -naphthyl)phenoxyipropionic acid }, Wy-14,643 1[4-chloro-6-(2,3-xylidino)-2-pyrimidinylthiolacetic acid }, tibric acid (2-chloro-5 -(3,5-dimethylpiperidinosulphonyl)benzoic acid) and BR-931 J[4-chloro-6-(2,3-xylidino)-2-pyrimidinylithio(N-,f-hydroxyethyl)acetamide } in order to ascertain if these hepatic peroxisome proliferators induce specific polypeptide(s). In an earlier study, we reported the enhanced synthesis of a polypeptide with a molecular weight of approx. 80 000 in all three subcellular fractions . Whether this polypeptide is specifically associated with drug-induced hepatic peroxisomes and/or microsomal fraction, or is induced in the membranes of all subcellular organelles, could not be ascertained. In the present studies, we have partially purified the 80000-mol.wt. polypeptide from livers of rats treated with peroxisome proliferators Wy-14,643, nafenopin, clofibrate and tibric acid and then made antibodies in rabbits to the partially purified polypeptide isolated from Wy-14,643-treated rat livers. These antibodies crossreacted with the 80000-mol.wt. polypeptide isolated from the livers of rats treated with other hypolipidaemic compounds. Studies using the Ouchterlony double-diffusion technique (Ouchterlony, 1967) indicate that the 80000-mol.wt. polypeptide induced by the peroxisome proliferators is not the microsomal NADPH-cytochrome P-450 reductase, which has the same approximate molecular weight of 80000.
Experimental

Materials
The hypolipidaemic drugs used in the present study were 
Treatment ofanimals
Inbred male F344 rats weighing 120-150g were obtained from A. R. Schmidt/Sprague-Dawley, Madison, WI, U.S.A. For studies on the induction of hepatic peroxisome proliferation, the hypolipidaemic drugs were administered in powdered rat chow diet for 4 weeks at the concentrations indicated (w/w): Wy-14,643, 0.1%: clofibrate, 0.25%; nafenopin, 0.1%; tibric acid, 0.2%. For induction of the microsomal enzymes, a group of rats was injected daily with phenobarbital (80mg/kg body wt.) intraperitoneally for 1 week. At the end of the treatment periods the animals were killed under light ether anaesthesia and their livers were perfused with cold normal saline (0.9% NaCl) to eliminate erythrocytes from the hepatic sinusoids. Subcellularfractionation
The perfused and minced livers were homo-
in a Potter-Elvehjem homogenizer. The unbroken cells and nuclei were removed by centrifugation at 700g for 10min in a Beckman J-2 IC centrifuge. The postnuclear supernatant was fractionated into postnuclear, large-particle and microsomal pellets as described by Kurup et al. (1970) . The postnuclear supernatant was centrifuged at 105 000g for 60min in a Beckman L5-65 ultracentrifuge to obtain the postnuclear pellet (consisting of all postnuclear membranes) or at 8300g for 10min in a Beckman J-21C centrifuge to obtain the large-particle pellet (consisting mostly of mitochondria, peroxisomes POLYPEPTIDE ASSOCIATED WITH HEPATIC PEROXISOME PROLIFERATION and lysosomes). The supernatant collected after sedimentation of the large-particle pellet was centrifuged at 105 OOOg for 60min in a Beckman L5-65 ultracentrifuge to obtain the microsomal pellet. All pellets were washed by resuspension in 0.25 Msucrose containing 0.03M-KCl and resedimented at the appropriate centrifugal force. The postnuclear supernatant from livers of control and Wy-14,643-treated rats was also fractionated as described by de Duve et al. (1955) into heavy-mitochondrial, light-mitochondrial and microsomal fractions. This was done with the hope that the separation of the two mitochondrial fractions would provide some clue about the subcellular localization of the 80000-mol.wt. polypeptide, because peroxisomes appear to sediment with the light-mitochondrial fraction.
Pure liver mitochondrial fractions were isolated by the method of Schneider (1948) ; the purity was assessed by electron microscopy. The postnuclear supernatant obtained from a 10% homogenate in 0.33 M-sucrose containing 10mM-Tris/HCl, pH 7.4, and 1 mM-EDTA was centrifuged at 8600g for 10min in a Beckman J-21C centrifuge to sediment the mitochondria. This pellet was resuspended in the homogenization medium and washed twice by sedimentation at 8300g for 10min to obtain pure mitochondria.
SDS/polyacrylamide-gel electrophoresis
Electrophoresis was performed on slab or cylindrical polyacrylamide gels by the method of Laemmli (1970) . Gels (7.5 or 10% polyacrylamide separating gels; 8cm long) were prepared from a stock of 30% acrylamide and 0.8% NN-methylenebisacrylamide. The (Laemmli, 1970) . Between 20 and 100,ug of dissolved protein was loaded on the cylindrical gels and electrophoresed with a current of 4 mA/tube until the tracking dye had reached the bottom of the gel. The slab gels were electrophoresed with a current of 20 mA/slab. After the completion of the run, the proteins were fixed by immersing the gels in 10% (w/v) trichloroacetic acid for 30min and then stained in 0.1% Coomassie Blue in 50% (v/v) methanol/10% (v/v) acetic acid. The cylindrical gels were stained overnight and the slab Vol. 188 gels for 2h. The gels were destained in 50% methanol/10% acetic acid and stored in 7.5% acetic acid/5% methanol.
The cylindrical gels were scanned at 540nm in a Beckman spectrophotometer (model 25). The area of the individual peaks was measured with a planimeter or by the area/weight method (M. K. .
Purification of 80000-mol.wt. polypeptide from rats treated with hypolipidaemic drugs
The peroxisomal protein was purified by using a Bio-Rad vertical-preparative-slab-electrophoresis apparatus model no. 220 fitted with an eluting canal. A plug gel of 30% polyacrylamide with 0.05% NNmethylenebisacrylamide was used at the bottom; this was followed by 2ml of 50% glycerol in 0.375M-Tris/HCl, pH 8.8, that served as the eluting canal. A separating gel of 7.5% polyacrylamide (30ml) was made above the eluting canal. After polymerization, a stacking gel (3%) was prepared. Postnuclear fractions obtained from livers of rats given hypolipidaemic drugs (Wy-14,643, nafenopin, clofibrate and tibric acid) were used for the purification of the 80000-mol.wt. polypeptide. The protein sample (5 mg/ml; 2 ml) was prepared by heating in the solubilizing sample buffer as described above and layered on the stacking gel. The electrophoresis was carried out with a current of 40 mA/slab at a constant voltage. When the tracking dye reached the eluting canal, fractions of volume 3 ml were collected and the A280 values measured. The fractions were analysed on SDS/polyacrylamide slab or cylindrical gel systems, and those containing the 80000-mol.wt. polypeptide were pooled, concentrated by freeze-drying and dialysed extensively against 0.02 M-Tris/HCl, pH 7.0, to remove SDS and lower the concentration of Tris/HCl.
Production of antibodies and characterization by
Ouchterlony double-diffusion analysis Five New Zealand white male rabbits weighing 2-3kg were immunized with the partially purified 80 000-mol.wt. polypeptide isolated from livers of rats treated with 0.1% Wy-14,643. Approx. 700-900,ug of polypeptide/ml was emulsified in equal volume of Freund's adjuvant (Difco, Detroit, MI, U.S.A.) and injected subcutaneously at multiple sites, at weekly intervals for 4 weeks. Then 1 week after the last injection, a booster injection of the polypeptide (without the adjuvant) was given intravenously and the rabbits were bled 5 days later. The y-globulins were prepared from the antisera by (NH4)2SO4 fractionation (Kabat & Mayer, 1961) and dialysed against 0.9% NaCl and then against deionized distilled water. The euglobulins that precipitated during dialysis were removed by cen-trifugation and the clear y-globulin fractions were kept frozen at -200C until used.
Ouchterlony plates were prepared by using 1% agarose in 0.1 M-Tris/barbiturate buffer, pH 8.6, containing lLM-NaN3 and 0.9% NaCI. The crossreactivity of partially purified 80000-mol.wt. polypeptides, the solubilized subcellular fractions from livers, the purified NADPH-cytochrome P-450 reductase or catalase with the antibody prepared against the 80000-mol.wt. polypeptide was analysed by allowing the Ouchterlony plates to develop for 30-35h at room temperature (22+20C) in a humidified chamber.
Enzyme assays
Catalase activity was assayed by the method of Lick (1963) . Carnitine . SDS/polyacrylamide-gel-electrophoretic analysis in the present study of the polypeptide composition of largeparticle, microsomal and postnuclear pellets obtained from the livers of rats treated with clofibrate, 643 , tibric acid and nafenopin confirmed the increase of this 80000-mol.wt. polypeptide (Fig. 1) . This polypeptide will be referred to as PPA-80 (PPA for peroxisome-proliferation-associated; 80 for 80000 mol.wt.), since it is increased in the livers with drug-induced peroxisome proliferation and not in the livers of rats treated with phenobarbital ( Fig. 2) and other microsomal enzyme inducers .
The distribution of polypeptide PPA-80 in the crude postnuclear, large-particle and microsomal fractions prepared from livers of rats treated with 0.1% (w/w) Wy-14,643 for 4 weeks was determined by SDS/polyacrylamide-gel electrophoresis. As shown in Table 1 animals approx. 70% of the polypeptide PPA-80 present in the post-nuclear fractions is recoverable in the large-particle pellet, and the remainder in the microsomal pellets (results not shown). SDS/polyacrylamide-gel-electrophoretic analysis of heavy-mitochondrial, light-mitochondrial, microsomal andpostmicrosomal-supernatant fractions
The electrophoretic patterns of the postnuclear, heavy-mitochondrial, light-mitochondrial, microsomal and postmicrosomal-supernatant fractions of liver from control and Wy-14,643-treated rats are shown in Fig. 3 . In general, the polypeptide PPA-80 increased in amount in all fractions obtained from the livers of rats treated with Wy-14,643 (Fig. 3 , slots 2, 4, 6, 8 and 10). Of particular interest, however, is the relative abundance of this polypeptide in the light-mitochondrial (Fig. 3, slot 6 ) and Fig. 4 . When fractions 6 and 7 (Fig. 4) diffusion assays, the antibodies gave a single precipitin line with the polypeptide PPA-80 antigen isolated from Wy-14,643-treated rat livers (Fig. 6a) . Since the antibodies were raised against polypeptide PPA-80 purified from Wy-14,643-treated rat livers, it was important to ascertain whether they would also react with the polypeptide PPA-80 isolated from the livers of rats treated with other hepatic peroxisome proliferators. As shown in Fig.  6(a) , the polypeptide PPA-80 from the livers of rats treated with different peroxisome proliferators reacted with the antibodies prepared against the polypeptide PPA-80 of Wy-14,643-treated rats and the precipitin lines were confluent, indicating immunological identity of the antigens.
The antibodies raised against the polypeptide PPA-80 from the rats treated with Wy-14,643 cross-reacted with the microsomal fractions prepared from rats treated with other peroxisome proliferators to give single precipitin lines of identity. However, purified rat liver catalase (Reddy & Kumar, 1979) did not cross-react with the antibodies against polypeptide PPA-80 (Fig. 6b, well 8 (Fig.   7) , it was necessary to investigate the possibility that the polypeptide PPA-80 induced by the hypolipidaemic peroxisome proliferators might be NADPH-cytochrome P-450 reductase. As shown in Fig. 8 , rabbit anti-(polypeptide PPA-80) antibody formed a single precipitin band with the purified polypeptide PPA-80 or with microsomal preparation from liver of Wy-14,643-treated rats. The anti-(rat liver NADPH-cytochrome P-450 reductase) antibody did not cross-react with the purified polypeptide PPA-80; however, as expected, a single precipitin band was observed with microsomal preparation from the Wy-14,643-treated rats. LikeVol. 188 wise, the purified rat liver NADPH-cytochrome P-450 reductase failed to react with the antibodies prepared against polypeptide PPA-80 (results not shown), suggesting that the polypeptide PPA-80 and NADPH-cytochrome P-450 reductase are antigenically dissimilar.
Discussion
The results of the SDS/polyacrylamide-gel-electrophoretic analysis of the polypeptide composition of the postnuclear, large-particle and microsomal membranes of rat liver reported in the present paper confirm a previous report from this laboratory of its increase in the liver with peroxisome proliferation.
In the present paper, we report the partial purification of polypeptide PPA-80 induced by the hypolipidaemic drugs Wy-14,643, nafenopin, clofibrate and tibric acid. The electrophoretic procedure produced a protein which was over 90% pure, as judged by SDS/polyacrylamide-gel electrophoresis, in a single step. The results of studies using antibodies to this protein produced in rabbits indicated that: (1) the 80000-mol.wt. peptide present in animals that have not been pretreated with peroxisome proliferators was antigenically identical with the polypeptide induced by Wy-14,643; (2) the 80000-mol.wt. polypeptides present in the three subcellular fractions were antigenically identical; (3) the protein was not present in purified mitochondria; and (4) the 80000-mol.wt. polypeptides induced by Wy-14,643, clofibrate, tibric acid and nafenopin were antigenically identical. Therefore all these hypolipidaemic agents induce the synthesis of the same 80000-mol.wt. polypeptide as determined by molecular weight and by antigenic properties.
Previous studies in our laboratory on the increases in the amounts of polypeptide PPA-80 in rats treated concurrently with Wy-14,643 and allylisopropylacetamide, an agent which inhibits catalase synthesis, suggested that this polypeptide was synthesized in the absence of the synthesis of enzymically active catalase . The results presented here, which demonstrate that antibodies to polypeptide PPA-80 do not cross-react with purified rat liver catalase, rule out the possibility that polypeptide PPA-80 might be an apoenzyme precursor form of catalase. Since there is no cross-reactivity between anti-(polypeptide PPA-80)antiserum and NADPH-cytochrome P-450 Although our studies indicate that polypeptide PPA-80 is induced by drugs which increase peroxisome proliferation, it is not certain if this polypeptide is localized exclusively in peroxisomes. The demonstration that polypeptide PPA-80 is present in all three subcellular fractions of the livers from rats pretreated with peroxisome proliferators may reflect the induction of this polypeptide in all cytoplasmic organelles or exclusively in the peroxisomes and/or the smooth endoplasmic reticulum. The relative increase of this polypeptide in the light-mitochondrial fraction when compared with the heavy-mitochondrial fraction suggests the localization of polypeptide PPA-80 in peroxisomes. The failure to obtain a clear-cut immunoprecipitin band with the highly purified mitochondria when reacted against anti-(polypeptide PPA-80) antibodies also suggests the localization of polypeptide PPA-80 in an organelle(s) other than mitochondria. Since polypeptide PPA-80 is also increased in microsomal fractions of livers of rats treated with peroxisome proliferators, it is possible that this may be due to:
(1) concomitant increase of this polypeptide in the endoplasmic reticulum (microsomal fraction), (2) contaminant smaller-sized proliferated peroxisomes or their limiting membranes, which may co-sediment with microsomal fractions as a result of partial or complete extraction of their matrix proteins during homogenization Leighton et al., 1975) ; or (3) the existence of numerous continuities between peroxisome membrane and smooth endoplasmic reticulum (Novikoff & Shin, 1964; ) that may share common membrane proteins. The possibility that this polypeptide is associated exclusively with peroxisomes is considered likely because polypeptide PPA-80 appears to be a major protein component (on SDS/polyacrylamide-gel electrophoresis) induced in livers by peroxisome proliferators and not by microsomalenzyme inducers. Additional studies, however, are necessary to establish unequivocally the subcellular localization of this polypeptide. This may be accomplished either by further subfractionation of cytoplasmic organelles to obtain a highly purified peroxisome fraction or by localizing the polypeptide PPA-80 at the ultrastructural level by immunoferritin or immuno-peroxidase procedures. The availability of antibodies to polypeptide should facilitate such studies.
The exact nature of the polypeptide PPA-80, as well as its role, if any, in drug-induced lipid metabolism remain to be ascertained. On the basis of structure-biological-activity studies with several 739 ow
